Expert Opinion :
The combination regimens used to treat active disease aim to eliminate actively replicating and dormant or near-dormant mycobacteria using a combination of drugs with different actions whilst preventing the emergence of drug-resistant organisms, and all being achieved with a minimum of toxicity.
Does anyone want to comment on action of ethambutol and ofloxacin on dormant or active bacilli_?